Single-cell sequencing revealed highly significant changes in the TME following treatment with MRTX1133.
← all excerpts
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer.
1
—
—
Single-cell sequencing revealed highly significant changes in the TME following treatment with MRTX1133.